Clinical Pharmacokinetics of Chlordiazepoxide
- 49 Downloads
Chlordiazepoxide was the first benzodiazepine derivative made available for clinical use. The metabolic pathway of chlordiazepoxide is complex, since the drug is biolransformed into a succession of pharmacologically active products: desmethylchlordiazepoxide, demoxepam, desmethyldiazepam, and oxazepam. The elimination half-life (t1/2β) chlordiazepoxide following single doses in healthy individuals generally ranges from 5 to 30 hours, and the volume of distribution from 0.25 to 0.50 liters/kg. The hepatic extraction ratio is well under 5 %. Elimination of the parent compound is mirrored by formation of the first active metabolite.
Clearance of chlordiazepoxide is reduced and (t1/2β) is prolonged in the elderly, in those with cirrhosis, and in those receiving concurrent disulfiram therapy. Oral chlordiazepoxide is rapidly and completely absorbed, but intramuscular injection is painful and results in slow and erratic absorption. Multiple-dose therapy with chlordiazepoxide results in accumulation of the parent compound, as well as two or more of its active metabolites. The rate and extent of accumulation varies considerably between individuals.
A relation between plasma concentrations of chlordiazepoxide and its metabolites to clinical effects has been suggested in some studies and is currently under further investigation.
KeywordsChlordiazepoxide Clinical Pharmacokinetic Oxazepam Steady State Plasma Concentration Single 25mg Oral Dose
Unable to display preview. Download preview PDF.
- Boxenbaum, H.G.; Geitner, K.A.; Jack, M.L.; Dixon, W.R.; Spiegel, H.E.; Symington, J.; Christian, R.; Moore, J.D.; Weissman, L. and Kaplan, S.A.: Pharmacokinetic and biopharmaceutic profile of chlordiazepoxide HC1 in healthy subjects: Single-dose studies by the intravenous, intramuscular, and oral routes. Journal of Pharmacokinetics and Biopharmaceutics 5: 3–23 (1977a).PubMedGoogle Scholar
- Ferguson, J.L. and Couri, D.: Electron capture gas chromatography determination of benzodiazepines and metabolites. Journal of Analytical Toxicology 1: 171–174 (1977).Google Scholar
- Gottschalk, L.A.; Biener, R. and Dinovo, E.C.: Effects of oral and intramuscular routes of administration on serum chlordiazepoxide levels and the prediction of these levels from predrug fasting serum glucose concentrations. Research Communications in Chemical Pathology and Pharmacology 8: 697–702 (1974).PubMedGoogle Scholar
- Greenblatt, D.J. and Shader, R.I.: Benzodiazepines in Clinical Practice (Raven Press, New York 1974).Google Scholar
- Greenblatt, D.J.; Shader, R.I.; Franke, K. and Harmatz, J.S.: Pharmacokinetics of chlordiazepoxide and metabolites following single and multiple oral doses. International Journal of Clinical Pharmacology and Biopharmacy. In press (1978b).Google Scholar
- Greenblatt, D.J.; Shader, R.I.; MacLeod, S.M.; Sellers, E.M.; Franke, K. and Giles, H.G.: Absorption of oral and intramuscular chlordiazepoxide. European Journal of Clinical Pharmacology. In press (1978a).Google Scholar
- Lin, K.-M. and Friedel, R.O.: Relationship of plasma levels of chlordiazepoxide and metabolites to clinical response. American Journal of Psychiatry. In press (1978).Google Scholar
- MacLeod, S.M.; Greenblatt, D.J. and Sellers, E.M.: Determination of intravenous chlordiazepoxide (CDX) pharmacokinetics: plasma versus blood. Clinical Research 25: 273A (1977).Google Scholar
- Randall, L.O. and Kappell, B.: Pharmacological activity of some benzodiazepines and their metabolites; in Garattini, Mussini and Randall (Eds) The Benzodiazepines, p. 27–51 (Raven Press, New York, 1973).Google Scholar
- Roberts, R.K.; Wilkinson, G.R.; Branch, R.A. and Schenker, S.: Effect of age and cirrhosis on the disposition and elimination of chlordiazepoxide (Librium). Gastroenterology 73: A45/1243 (1977).Google Scholar
- Sellers, E.M.; MacLeod, S.M. and Greenblatt, D.J.: Unpublished data (1978).Google Scholar
- Sellers, E.M.; MacLeod, S.M.; Greenblatt, D.J. and Giles, H.G.: Inhibition of chlordiazepoxide biotransformation by disulfiram. Clinical Research 24: 652A (1976).Google Scholar
- Sellers, E.M.; MacLeod, S.M.; Greenblatt, D.J. and Giles, H.G.: Influence of disulfiram and disease on benzodiazepine disposition. Clinical Pharmacology and Therapeutics 21: 117 (1977).Google Scholar